Peripheral nerve repair occupies an unusual position in translational neuroscience. The biology is more permissive than in the central nervous system, since peripheral axons can regenerate, and yet functional recovery after a serious injury is often disappointing. A transected nerve with a substantial gap, repaired late, frequently produces axons that grow but reach the wrong targets, arrive after the distal muscle has begun to atrophy, or remyelinate poorly. The autologous nerve graft remains the clinical reference standard, but it carries donor site morbidity and a limited supply of suitable tissue, which is why a sustained effort continues across conduits, scaffolds, hydrogels, and biologic fillers aimed at matching or improving on the graft. The difficulty for any of these programs is that early efficacy claims rest entirely on how regeneration is measured, and "axons are present" is not the same finding as "the nerve works again."
The most basic regeneration endpoint is total axon count and density across the repair site, and it answers a real question about whether fibers crossed the lesion. On its own, however, it can mislead. A repair can generate a high number of thin, poorly myelinated, disorganized axons that conduct slowly and connect to nothing useful. To distinguish quantity from quality, the histological panel has to read myelination and fiber maturity alongside raw counts. The G-ratio, the ratio of axon diameter to total fiber diameter including myelin, is the standard measure of remyelination quality, and it separates a nerve that has regenerated functional, well insulated fibers from one that has merely filled the conduit with axoplasm. NF200 marks large myelinated fibers and reports on the integrity of the population most relevant to motor and fast sensory function, while beta-III tubulin, often read as Tuj1, provides a pan-neuronal measure of axon integrity.
Schwann cell behavior deserves its own readout because regeneration depends on it. S100b identifies Schwann cells and reveals whether they have recolonized the repair site to support and remyelinate the incoming axons. A repair that axons enter but Schwann cells do not is a repair that will not mature, and the S100b signal is what flags that failure mode before the functional data would.
The endpoints clinicians and sponsors ultimately care about are functional, and histology can speak to function directly if the right markers are included. Motor endplate reinnervation, assessed distal to the injury, indicates whether regenerated motor axons have actually reconnected to muscle and reestablished the neuromuscular junction, which is the structural prerequisite for any recovery of voluntary movement. Distal muscle fiber size is the complementary readout, since denervated muscle atrophies in a measurable way and its recovery tracks the success of reinnervation. Reading these two together turns a histology dataset from a description of the nerve into an account of whether the motor pathway has a realistic chance of working.
Functional electrophysiology closes the loop. The compound muscle action potential reports motor nerve and neuromuscular junction function in the living animal, and sensory nerve conduction measures complete the picture on the sensory side. A regeneration package that pairs axon counts and G-ratio with motor endplate reinnervation, distal muscle morphometry, and a conduction measurement is internally cross checked in a way that a count alone can never be.
Most nerve repair data is generated in rodents, and for early work that is appropriate. Rat models of nerve dissection and repair are efficient, well characterized, and entirely suitable for screening conduits and ranking candidates, with functional readouts such as computerized gait analysis showing how the animal loads and uses the affected limb. What rodents cannot provide is scale. A rat nerve is short, the gaps that can be bridged are small, and the regeneration distances are nothing like those a human nerve faces, which matters because the central challenge in clinical nerve repair is getting axons to grow across a long gap and reach distant targets before the denervated muscle atrophies.
This is where a large animal becomes necessary, and the pig is well suited to the role. Göttingen minipig nerve repair models can simulate the critical size gaps that defeat smaller models and accommodate the wraps, conduits, and fillers that a device or biologic program needs to evaluate at something approaching clinical dimensions. The study durations match the biology as well, running from six months to a year, long enough for regeneration across a substantial gap and for reinnervation of distal muscle to actually occur rather than being inferred from an early timepoint. In a peroneal nerve dissection and repair model, computerized gait analysis shows the expected reduction in weight bearing on the operated leg, and peripheral electrophysiology adds compound muscle action potential and sensory nerve action potential readouts, all assessed against commercial conduit controls. Run with the histological panel described above, a minipig study evaluates a repair technology under conditions of gap length, regeneration distance, and recovery timeline that resemble the clinical problem far more closely than any rodent design can.
The practical implication for a nerve repair program is that the endpoint set should be chosen to match the claim the program intends to make. A conduit positioned on speed of regeneration needs longitudinal conduction and axon counts. A biologic positioned on the quality of recovery needs G-ratio, motor endplate reinnervation, and distal muscle morphometry. A candidate that must perform across a long gap needs a model that imposes a clinically relevant gap length and regeneration distance, which is where the staged use of an efficient rat screen followed by a Göttingen minipig study earns its place, since a candidate that only succeeds across a short rodent gap has not been tested against the distances it will face in patients. Where a program's mechanism calls for a marker outside the standard panel, custom immunohistochemistry markers can be validated and added, so the readout follows the biology rather than forcing the biology into a fixed list.
MD Biosciences runs peripheral nerve injury and repair models with this full histological and functional endpoint set, from axon quantification and G-ratio through motor endplate reinnervation, distal muscle morphometry, and integrated electrophysiology, in rat and Göttingen minipig formats. For sponsors scoping a nerve repair study and deciding which endpoints will support the intended claim, study design discussions are welcome at neuro@mdbiosciences.com.